2024-09-23 - Analysis Report
## Amgen Inc. (AMGN) Stock Analysis:

**Company Overview:** Amgen Inc. is a leading biotechnology company that develops, manufactures, and markets a wide range of prescription medicines.

**Performance Analysis:**

**1) Relative Performance:**

* **Cumulative Return:** 89.06% (AMGN) vs. 132.53% (VOO - S&P 500)
* **Relative Lag:** -43.47% (AMGN is trailing VOO by 43.47%). This is within the 42.31% range of its historical relative performance, suggesting it's not performing exceptionally well or poorly compared to its historical performance against the S&P 500.

**2) Recent Price Action:**

* **Closing Price:** $337.38
* **Moving Averages:** 
    * 5-day: $334.73
    * 20-day: $330.19
    * 60-day: $326.95

The stock is currently trading above its short-term moving averages, suggesting positive momentum. However, the relatively small difference between the 5-day and 20-day moving averages indicates a potential for consolidation or slight correction.

**3) Technical Indicators:**

* **RSI:** 54.82, suggesting the stock is neither overbought nor oversold. 
* **PPO:** 0.23, indicating positive momentum, but it's closer to neutral territory.
* **Delta_Previous_Relative_Divergence:** 1.69, suggesting a short-term upward trend. 
* **Expected_Return:** 9.0%, indicating potential for 9% return over the next 5 years, based on current investment.

**4) Recent Earnings and Outlook:**

| Date | EPS | Revenue | 
|---|---|---|
| 2024-08-07 | 1.39 | 8.39 B$ | 
| 2024-05-03 | -0.21 | 7.45 B$ |
| 2023-10-31 | 3.23 | 6.90 B$ |
| 2023-08-04 | 2.58 | 6.99 B$ |
| 2024-08-07 | 2.58 | 6.99 B$ |

* **Recent Earnings:** The most recent earnings (2024-08-07) exceeded analyst expectations by $0.14 per share. 
* **Revenue Growth:** Revenue has been consistently increasing over the past several quarters.

**Overall Analysis:**

AMGN stock is currently in a neutral position. While it's showing positive momentum with its recent price action and earnings beat, it's lagging behind the S&P 500 in the long term. The technical indicators suggest a slight upward trend, but the RSI and PPO are closer to neutral territory. The expected return of 9% over the next 5 years is a positive sign, suggesting potential for growth. However, investors should monitor the stock closely for any signs of consolidation or correction, given its relatively small distance from its moving averages. Further research into the company's future growth prospects and potential catalysts is needed to form a more definitive opinion. 
